Amicus Therapeutics Liabilities 2024

Amicus Therapeutics Aktienanalyse

What does Amicus Therapeutics do?

Amicus Therapeutics Inc. is a biopharmaceutical company specializing in the development of drugs for the treatment of rare diseases. The company was founded in 2002 and is headquartered in Cranbury, New Jersey. Amicus Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Amicus Therapeutics's Liabilities

Amicus Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Amicus Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Amicus Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Amicus Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Amicus Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Amicus Therapeutics stock

What is the level of liabilities of Amicus Therapeutics this year?

Amicus Therapeutics has a debt balance of 617.71 M USD this year.

What were the liabilities of Amicus Therapeutics compared to the previous year?

The liabilities of Amicus Therapeutics have increased by 2.76% increased compared to the previous year.

What are the consequences of high debt for investors of Amicus Therapeutics?

High liabilities can pose a risk for investors of Amicus Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Amicus Therapeutics?

Low liabilities mean that Amicus Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Amicus Therapeutics affect the company?

An increase in liabilities of Amicus Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Amicus Therapeutics affect the company?

A decrease in the liabilities of Amicus Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Amicus Therapeutics?

Some factors that can influence the liabilities of Amicus Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Amicus Therapeutics so important for investors?

The liabilities of Amicus Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Amicus Therapeutics take to modify the liabilities?

To change its liabilities, Amicus Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Amicus Therapeutics pay?

Over the past 12 months, Amicus Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amicus Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Amicus Therapeutics?

The current dividend yield of Amicus Therapeutics is .

When does Amicus Therapeutics pay dividends?

Amicus Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amicus Therapeutics?

Amicus Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Amicus Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amicus Therapeutics located?

Amicus Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amicus Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amicus Therapeutics from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Amicus Therapeutics pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Amicus Therapeutics in the year 2023?

In the year 2023, Amicus Therapeutics distributed 0 USD as dividends.

In which currency does Amicus Therapeutics pay out the dividend?

The dividends of Amicus Therapeutics are distributed in USD.